These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 16889822

  • 1. Phase I trial of concurrent chemoradiation with weekly nedaplatin in patients with squamous cell carcinoma of the uterine cervix.
    Yoshinaga K, Niikura H, Ogawa Y, Nemoto K, Nagase S, Takano T, Ito K, Yaegashi N.
    Gynecol Oncol; 2007 Jan; 104(1):36-40. PubMed ID: 16889822
    [Abstract] [Full Text] [Related]

  • 2. A phase II multicenter trial of concurrent chemoradiotherapy with weekly nedaplatin in advanced uterine cervical carcinoma: Tohoku Gynecologic Cancer Unit Study.
    Yokoyama Y, Takano T, Nakahara K, Shoji T, Sato H, Yamada H, Yaegashi N, Okamura K, Kurachi H, Sugiyama T, Tanaka T, Sato A, Tase T, Mizunuma H.
    Oncol Rep; 2008 Jun; 19(6):1551-6. PubMed ID: 18497964
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Concurrent chemoradiation therapy with nedaplatin for high-risk cervical cancer--clinical investigation of adverse events].
    Kamiura S, Kobayashi K, Ohira H, Seino H, Hashimoto N, Sawai K, Samejima Y, Saji F.
    Gan To Kagaku Ryoho; 2001 Jul; 28(7):979-86. PubMed ID: 11478148
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A dose-finding and pharmacokinetic study of nedaplatin in elderly patients with advanced non-small cell lung cancer.
    Yamamoto N, Tamura T, Kurata T, Yamamoto N, Sekine I, Kunitoh H, Ohe Y, Saijo N.
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):79-88. PubMed ID: 19396598
    [Abstract] [Full Text] [Related]

  • 9. [A dose escalation study of concurrent chemoradiation therapy with nedaplatin for cervical cancer].
    Hatae M, Takahashi T, Kodama S, Nakayama H, Kuzuya K, Saji F, Kamiura S, Watanabe Y, Nishimura R, Kono I, Ariyosh Y, Fukuoka M, Imajo Y, Hasegawa K, Noda K, Efficacy and, Safety Assessment Committee.
    Gan To Kagaku Ryoho; 2005 Apr; 32(4):473-8. PubMed ID: 15853213
    [Abstract] [Full Text] [Related]

  • 10. [Phase II clinical trial of home-produced Nedaplatin in treating advanced esophageal carcinoma].
    Xu RH, Shi YX, Guan ZZ, Jiang WQ, Huang H, Ma ZY, Wang JH, Hu XH, Xie WM, Li XG, Liu YL, Pan LX, Dai AD, Zhuang W, Zhang C.
    Ai Zheng; 2006 Dec; 25(12):1565-8. PubMed ID: 17166388
    [Abstract] [Full Text] [Related]

  • 11. [Concurrent weekly nedaplatin-based radiotherapy for high risk, recurrent and advanced cervical cancer].
    Idei T, Sakamoto H, Nakajima Y, Hiraiwa Y, Takami N, Chishima F, Ohtani K, Nagaishi M, Yamamoto T, Kawamori J, Himi K, Tanaka Y.
    Gan To Kagaku Ryoho; 2003 Apr; 30(4):505-9. PubMed ID: 12722682
    [Abstract] [Full Text] [Related]

  • 12. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
    Gatcliffe TA, Tewari KS, Shah A, Brewster WR, Burger RA, Kuo JV, Monk BJ.
    Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Phase II study of radiation therapy combined with weekly nedaplatin in locally advanced uterine cervical carcinoma (LAUCC): Kitasato Gynecologic Radiation Oncology Group (KGROG 0501)--initial analysis.
    Niibe Y, Tsunoda S, Jobo T, Imai M, Matsuo K, Matsunaga K, Unno N, Hayakawa K.
    Eur J Gynaecol Oncol; 2008 Jan; 29(3):222-4. PubMed ID: 18592783
    [Abstract] [Full Text] [Related]

  • 16. Phase I study of topotecan and radiation therapy in advanced cervical cancer.
    Dunton CJ, King SA, Neufeld J, Tolosa J, Perez G, Avila A, Underhill K.
    Gynecol Oncol; 2002 Apr; 85(1):185-7. PubMed ID: 11925142
    [Abstract] [Full Text] [Related]

  • 17. Five years' experience treating locally advanced cervical cancer with concurrent chemoradiotherapy and high-dose-rate brachytherapy: results from a single institution.
    Parker K, Gallop-Evans E, Hanna L, Adams M.
    Int J Radiat Oncol Biol Phys; 2009 May 01; 74(1):140-6. PubMed ID: 18922646
    [Abstract] [Full Text] [Related]

  • 18. Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion.
    Huguet F, Cojocariu OM, Levy P, Lefranc JP, Darai E, Jannet D, Ansquer Y, Lhuillier PE, Benifla JL, Seince N, Touboul E.
    Int J Radiat Oncol Biol Phys; 2008 Dec 01; 72(5):1508-15. PubMed ID: 18676093
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of satraplatin (JM216), an oral platinum (IV) complex under daily oral administration for 5 or 14 days.
    Vouillamoz-Lorenz S, Buclin T, Lejeune F, Bauer J, Leyvraz S, Decosterd LA.
    Anticancer Res; 2003 Dec 01; 23(3C):2757-65. PubMed ID: 12926110
    [Abstract] [Full Text] [Related]

  • 20. Phase I study of chemoradiation with nedaplatin and ifosfamide in patients with advanced squamous cell carcinoma of the uterine cervix.
    Kodama J, Takemoto M, Seki N, Nakamura K, Hongo A, Moriya S, Kanazawa S, Hiramatsu Y.
    Int J Gynecol Cancer; 2008 Dec 01; 18(6):1300-4. PubMed ID: 18284451
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.